Hims & Hers Health Registered (A) WKN: A2QMYY ISIN: US4330001060 Forum: Aktien Thema: Hauptdiskussion

Hims & Hers Health insiders have traded $HIMS stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales. Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months: ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 40 sales selling 1,718,525 shares for an estimated $88,599,546. OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 13 sales selling 369,364 shares for an estimated $20,394,289. MICHAEL CHI (Chief Commercial Officer) has made 0 purchases and 13 sales selling 91,401 shares for an estimated $5,410,838. PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 2 sales selling 70,021 shares for an estimated $3,720,938. SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 12 sales selling 35,261 shares for an estimated $1,907,839. MELISSA BAIRD (Chief Operating Officer) has made 0 purchases and 4 sales selling 33,333 shares for an estimated $1,867,376. IRENE BECKLUND (PAO) has made 0 purchases and 3 sales selling 21,966 shares for an estimated $1,203,032.

Überlege tatsächlich auch Hims zu verkaufen und in einen NASDAQ100 Etf zu stecken. Das bringt mehr

Erlebt Hims nicht gerade gefühlt als einziger eine Korrektur ?

Immer angenehm wenn‘s hier ruhiger wird 😊 Die Aktie hat trotz der hohen Shortquote 100% gemacht und ist immer noch unterbewertet. Bis bald 👋

Mein Sell Order wurde bei 41€ ausgeführt. Bei 0%